DHE2_PSEAE
ID DHE2_PSEAE Reviewed; 1620 AA.
AC Q9HZE0; Q7BHF2;
DT 20-APR-2010, integrated into UniProtKB/Swiss-Prot.
DT 01-MAR-2001, sequence version 1.
DT 03-AUG-2022, entry version 107.
DE RecName: Full=NAD-specific glutamate dehydrogenase {ECO:0000305};
DE Short=NAD-GDH {ECO:0000303|PubMed:11133942};
DE EC=1.4.1.2 {ECO:0000269|PubMed:11133942};
DE AltName: Full=NAD(+)-dependent glutamate dehydrogenase {ECO:0000303|PubMed:11133942};
GN Name=gdhB; OrderedLocusNames=PA3068;
OS Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM
OS 14847 / LMG 12228 / 1C / PRS 101 / PAO1).
OC Bacteria; Proteobacteria; Gammaproteobacteria; Pseudomonadales;
OC Pseudomonadaceae; Pseudomonas.
OX NCBI_TaxID=208964;
RN [1]
RP NUCLEOTIDE SEQUENCE [GENOMIC DNA], PROTEIN SEQUENCE OF 2-11, FUNCTION,
RP CATALYTIC ACTIVITY, ACTIVITY REGULATION, BIOPHYSICOCHEMICAL PROPERTIES,
RP SUBUNIT, INDUCTION, AND DISRUPTION PHENOTYPE.
RX PubMed=11133942; DOI=10.1128/jb.183.2.490-499.2001;
RA Lu C.D., Abdelal A.T.;
RT "The gdhB gene of Pseudomonas aeruginosa encodes an arginine-inducible
RT NAD(+)-dependent glutamate dehydrogenase which is subject to allosteric
RT regulation.";
RL J. Bacteriol. 183:490-499(2001).
RN [2]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC STRAIN=ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C /
RC PRS 101 / PAO1;
RX PubMed=10984043; DOI=10.1038/35023079;
RA Stover C.K., Pham X.-Q.T., Erwin A.L., Mizoguchi S.D., Warrener P.,
RA Hickey M.J., Brinkman F.S.L., Hufnagle W.O., Kowalik D.J., Lagrou M.,
RA Garber R.L., Goltry L., Tolentino E., Westbrock-Wadman S., Yuan Y.,
RA Brody L.L., Coulter S.N., Folger K.R., Kas A., Larbig K., Lim R.M.,
RA Smith K.A., Spencer D.H., Wong G.K.-S., Wu Z., Paulsen I.T., Reizer J.,
RA Saier M.H. Jr., Hancock R.E.W., Lory S., Olson M.V.;
RT "Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic
RT pathogen.";
RL Nature 406:959-964(2000).
RN [3]
RP INDUCTION BY ARGININE.
RX PubMed=9286980; DOI=10.1128/jb.179.17.5300-5308.1997;
RA Park S.-M., Lu C.-D., Abdelal A.T.;
RT "Cloning and characterization of argR, a gene that participates in
RT regulation of arginine biosynthesis and catabolism in Pseudomonas
RT aeruginosa PAO1.";
RL J. Bacteriol. 179:5300-5308(1997).
CC -!- FUNCTION: Involved in arginine catabolism by converting L-glutamate,
CC into 2-oxoglutarate, which is then channeled into the tricarboxylic
CC acid cycle. Can also utilize other amino acids of the glutamate family.
CC {ECO:0000269|PubMed:11133942}.
CC -!- CATALYTIC ACTIVITY:
CC Reaction=H2O + L-glutamate + NAD(+) = 2-oxoglutarate + H(+) + NADH +
CC NH4(+); Xref=Rhea:RHEA:15133, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC ChEBI:CHEBI:16810, ChEBI:CHEBI:28938, ChEBI:CHEBI:29985,
CC ChEBI:CHEBI:57540, ChEBI:CHEBI:57945; EC=1.4.1.2;
CC Evidence={ECO:0000269|PubMed:11133942};
CC -!- ACTIVITY REGULATION: Activity subject to allosteric control by arginine
CC and citrate, which function as positive and negative effectors,
CC respectively. {ECO:0000269|PubMed:11133942}.
CC -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC Kinetic parameters:
CC KM=0.13 uM for NAD {ECO:0000269|PubMed:11133942};
CC pH dependence:
CC Optimum pH is 8 for amination, and 9 for deamination.
CC {ECO:0000269|PubMed:11133942};
CC -!- SUBUNIT: Homotetramer. {ECO:0000269|PubMed:11133942}.
CC -!- INDUCTION: Expression induced by arginine in an ArgR-dependent manner
CC (27-fold). Induced to a much lesser extent by ornithine, glutamate, and
CC aspartate (1.7- to 5-fold). {ECO:0000269|PubMed:11133942,
CC ECO:0000269|PubMed:9286980}.
CC -!- PTM: Contains disulfide bonds (interchain). {ECO:0000305}.
CC -!- DISRUPTION PHENOTYPE: Reduced growth when arginine serve as the sole
CC source of carbon and nitrogen. {ECO:0000269|PubMed:11133942}.
CC -!- SIMILARITY: Belongs to the Glu/Leu/Phe/Val dehydrogenases family.
CC {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; AF315586; AAG53963.1; -; Genomic_DNA.
DR EMBL; AE004091; AAG06456.1; -; Genomic_DNA.
DR PIR; E83261; E83261.
DR RefSeq; NP_251758.1; NC_002516.2.
DR RefSeq; WP_003103491.1; NZ_QZGE01000009.1.
DR AlphaFoldDB; Q9HZE0; -.
DR SMR; Q9HZE0; -.
DR STRING; 287.DR97_4868; -.
DR PaxDb; Q9HZE0; -.
DR PRIDE; Q9HZE0; -.
DR EnsemblBacteria; AAG06456; AAG06456; PA3068.
DR GeneID; 878664; -.
DR KEGG; pae:PA3068; -.
DR PATRIC; fig|208964.12.peg.3219; -.
DR PseudoCAP; PA3068; -.
DR HOGENOM; CLU_003404_1_1_6; -.
DR InParanoid; Q9HZE0; -.
DR OMA; RATRWFL; -.
DR PhylomeDB; Q9HZE0; -.
DR BioCyc; PAER208964:G1FZ6-3121-MON; -.
DR Proteomes; UP000002438; Chromosome.
DR GO; GO:0004352; F:glutamate dehydrogenase (NAD+) activity; IDA:CACAO.
DR GO; GO:0019551; P:glutamate catabolic process to 2-oxoglutarate; IEA:InterPro.
DR InterPro; IPR046346; Aminiacid_DH-like_N_sf.
DR InterPro; IPR036291; NAD(P)-bd_dom_sf.
DR InterPro; IPR028971; NAD-GDH.
DR InterPro; IPR007780; NAD_Glu_DH_bac.
DR PANTHER; PTHR43403; PTHR43403; 1.
DR Pfam; PF05088; Bac_GDH; 1.
DR PIRSF; PIRSF036761; GDH_Mll4104; 1.
DR SUPFAM; SSF51735; SSF51735; 1.
DR SUPFAM; SSF53223; SSF53223; 1.
PE 1: Evidence at protein level;
KW Direct protein sequencing; Disulfide bond; NAD; Oxidoreductase;
KW Reference proteome.
FT INIT_MET 1
FT /note="Removed"
FT /evidence="ECO:0000269|PubMed:11133942"
FT CHAIN 2..1620
FT /note="NAD-specific glutamate dehydrogenase"
FT /id="PRO_0000393369"
FT ACT_SITE 851
FT /evidence="ECO:0000250"
SQ SEQUENCE 1620 AA; 182638 MW; 1AF2AE56BE3274C3 CRC64;
MAFFTAASKA DFQHQLQTAL AQHLGDKALP QVTLFAEQFF SLISLDELTQ RRLSDLVGCT
LSAWRLLERF DRDQPEVRVY NPDYEKHGWQ STHTAVEVLH PDLPFLVDSV RMELNRRGYS
IHTLQTNVLS VRRSAKGELK EILPKGSQGK DVSQESLMYL EIDRCAHAGE LRALEKAILE
VLGEVRVTVA DFEPMKAKAR ELLTWLGKAK LKVPAEELKE VRSYLEWLLD NHFTFLGYEE
FSVADEADGG RMVYDEKSFL GLTRLLRAGL SKDDLHIEDY AVAYLREPVL LSFAKAAHPS
RVHRPAYPDY VSIRELDGKG RVIRECRFMG LFTSSVYNES VNDIPFIRGK VAEVMRRSGF
DTKAHLGKEL AQVLEVLPRD DLFQTPVDEL FSTALAIVRI QERNKIRVFL RKDPYGRFCY
CLAYVPRDVY STETRLKIQQ VLMERLQASD CEFWTFFSES VLARVQFILR VDPKSRIDID
PARLEEEVIQ ACRSWQDDYS SLVVENLGEA KGTNVLADFP KGFPAGYRER FAPHFAVVDL
QHLLSLSEQR PLVMSFYQPL AQGEQQLHCK LYHADTPLAL SDVLPILENL GLRVLGEFPY
RLRHQNGREY WIHDFAFTYA EGLDVDIQQL NEILQDAFVH IVSGDAENDA FNRLVLTANL
PWRDVALLRA YARYLKQIRL GFDLGYIASA LNAHTDIARE LVRLFKTRFY LARKLTAEDL
EDKQQKLEQA ILGALDEVQV LNEDRILRRY LDLIKATLRT NFYQPDGNGQ NKSYFSFKFN
PKAIPELPRP VPKYEIFVYS PRVEGVHLRG GKVARGGLRW SDREEDFRTE VLGLVKAQQV
KNAVIVPVGA KGGFVPRRLP LGGSRDEIQA EAIACYRIFI SGLLDITDNL KEGEVVPPAN
VVRHDEDDPY LVVAADKGTA TFSDIANGIA AEYGFWLGDA FASGGSAGYD HKGMGITAKG
AWVSVQRHFR ERGIDVQKDN ISVIGIGDMA GDVFGNGLLM SDKLQLVAAF NHMHIFIDPN
PDAASSFVER QRLFNLPRSS WADYDAKLIS AGGGIFLRSA KSIAITPEMK ARFDIQADRL
APTELIHALL KAPVDLLWNG GIGTYVKSSK ETHADVGDKA NDGLRVDGRE LRAKVVGEGG
NLGMTQLARV EFGLHGGANN TDFIDNAGGV DCSDHEVNIK ILLNEVVQAG DMTEKQRNAL
LVKMTDAVGA LVLGNNYKQT QALSLAQRRA RERIAEYKRL MGDLEARGKL DRALEFLPSD
EELAERISAG QGLTRAELSV LISYSKIDLK ESLLKSLVPD DDYLTRDMET AFPALLAEKF
GDAMRRHRLK REIVSTQIAN DLVNHMGITF VQRLKESTGM SAANVAGAYV IVRDVFHLPH
WFRQIENLDY QVPADIQLTL MDELMRLGRR ATRWFLRSRR NELDAARDVA HFGPRIAALG
LKLNELLEGP TRELWQARYQ TYVDAGVPEL LARMVAGTSH LYTLLPIIEA SDVTGQDTAE
VAKAYFAVGS ALDLTWYLQQ ITNLPVENNW QALAREAFRD DLDWQQRAIT VSVLQMQDGP
KEVEARVGLW LEQHLPLVER WRAMLVELRA ASGTDYAMYA VANRELMDLA QSSQHGVCIP